Clinical Excellence
Featured Stories
Evaluating Innovations in Middle Molecule Clearance
Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems
SGLT2 Inhibitors Could Play Role in Slowing Kidney Disease Progression
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Clinical Excellence
-
Protecting Our Most Vulnerable: The Critical Role of Flu Vaccination for Dialysis Patients
Brendan Bowman, MD, vice president of medical affairs for DaVita Kidney Care As nephrologists, we are on the front lines of managing one of the most complex and vulnerable patient populations. Our…
-
A Future Reimagined Through Choice, Trust and Empowerment
For Franz Nolan, hearing the words “kidney failure” brought back difficult memories. His father’s long struggle with kidney disease made the idea of dialysis feel overwhelming. “I’d just…
-
Chain of Hope: Multi-Patient Transplant Amplifies Live-Saving Gift
When Hailey Boss was admitted to Chillicothe Dialysis, a DaVita center in Missouri, she was just 18 years old and dealing with the overwhelming emotion of her diagnosis. She had been recently…
-
“It’s a Balancing Act:” Nephrologist Shares Importance of Advancing Value-Based Kidney Care
In 2001, the Institute of Medicine’s “Crossing the Quality Chasm” report identified six critical areas for improvement in the American healthcare system, urging fundamental changes to…
-
Keep Moving Forward: How George Godoy Transformed His Dialysis Experience
At just 16 years old, George Godoy received life-altering news: He had been born with one kidney affected by polycystic kidney disease. When he finished high school, Godoy watched as friends and…
